| The use of different prognostic systems applied to myelodysplastic syndromes: A retrospective analysis | Fatih DEMİRKAN,Mine ÇABUK,G. Hayri ÖZSAN,MUSTAFA PEHLİVAN,Erdinç YÜKSEL,İlhan ÖZTOP,Bülent ÜNDAR | 101–109 |
| Immunosuppressive therapy-induced hepatotoxicity in patients with aplastic anemia | İmdat DİLEK,Ramazan İDİLMAN,Semin FENKÇİ,Celalettin ÜSTÜN,Haluk KOÇ,Osman İLHAN,Hamdi AKAN | 111–117 |
| Natural inhibitors and lipids in patients with sickle cell disease | Duran CANATAN,Nurgül OĞUZ,Ahmet ÖZSANCAK,İbrahim ASLAN,Aynur BENGÜ,Alim GÜRMAN,Bekir SARICA | 119–122 |
| Hematological values of healthy adult population living at moderate altitude (1869 m, Erzurum, Turkey) | Hasan KAYA,İlhami KİKİ,Ersin AKARSU,Mehmet GÜNDOĞDU,S. Başol TEKİN,Tacettin İNANDI | 123–128 |
| Ticlopidine induced anemia and agranulocytosis | Ali KESKİN,Yurdaer SERMEZ | 129–132 |
| Multiple cerebral emboli in a homozygous $\beta$-thalassaemia patient due to factor V 1299 (His-Arg) 4070 A-G mutation | Nejat AKAR,Sabri KEMAHLI,Gülhis DEDA,Ece AKAR,Erkan YILMAZ,Zümrüt UYSAL,Şükrü CİN | 133–136 |
| Multiple cerebral emboli in a homozygous $beta$-thalassaemia patient due to factor V 1299 (His-Arg) 4070 A-G mutation | Nejat AKAR, Şükrü CİN, Gülhis DEDA, Sabri KEMAHLI, Zümrüt UYSAL, Erkan YILMAZ, Ece AKAR | 133–136 |
| Could parvovirus B19 induce a rejection after bone marrow transplantation in a patient with Diamond-Blackfan anemia? | Nevin YALMAN,Sema ANAK,Nazan SARPER,Hülya BİLGEN,Semra ÖZGENÇ,Emine CAN,Gündüz GEDİKOĞLU | 137–141 |